Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants

Infectious Diseases in Obstetrics and Gynecology

Volumn 13, Issue 2, 2005, Pages 59-61

  Gonik, Bernard ^a   Puder, Karoline S ^a   Gonik, Nathan ^b   Kruger, Michael ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Immunity; Neonatal; Pertussis; Pregnancy

Indexed keywords

HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; PERTACTIN; PERTUSSIS TOXIN;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETOMATERNAL TRANSFUSION; GESTATIONAL AGE; HEALTH CARE PERSONNEL; HUMAN; IMMUNIZATION; INFANT; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN; PERTUSSIS; PREGNANCY; PRIORITY JOURNAL; SEROPREVALENCE; UMBILICAL CORD BLOOD; URBAN AREA; VERTICAL TRANSMISSION;

ADULT; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BORDETELLA PERTUSSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HEMAGGLUTININS; HUMANS; INFANT, NEWBORN; MICHIGAN; PREGNANCY; SEROEPIDEMIOLOGIC STUDIES; STATISTICS, NONPARAMETRIC; TOXOIDS; URBAN POPULATION; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 22144488081     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440500068289     Document Type: Article

References (12)

1. Centers for Disease Control and Prevention. Pertussis - USA, 1997-2000. MMWR recomm Rep 2002;51(4):73-76.
2. Yih WK, Lett SM, des Vignes FN, et al. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000;182:1409-1416.
3. Wright SW. Pertussis infection in adults. South Med J 1998;91:702-708.
4. Centers for Disease Control and Prevention. Guidelines for the control of pertussis outbreaks. Atlanta, GA, USA: Centers for Disease Control and Prevention; 2000.
5. Van de Wielen M, Van Damme P, Van Herck K, et al. Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium). Vaccine 2003;21:2412-2417.
6. Healy CM, Munoz FM, Rench MA, et al. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004;190:335-340.
7. Belloni C, DeSilvestri A, Tinelli C, et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003;111:1042-1045.
8. Storsaeter J, Hallender HO, Gustafsson L, Olin P. Levels of anti-pertussin antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998;16:1907-1916.
9. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998;16:1901-1906.
10. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the USA: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28:1230-1237.
11. Edwards KM. Pertussis: an important target for maternal immunization. Vaccine 2003;21:3483-3486.
12. Health Canada. National consensus conference on pertussis. Canada Communicable Disease Report 2001;2953:1-33.